Gujarat Terce Laboratories Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Gujarat Terce Laboratories has a total shareholder equity of ₹88.6M and total debt of ₹39.4M, which brings its debt-to-equity ratio to 44.5%. Its total assets and total liabilities are ₹248.4M and ₹159.8M respectively. Gujarat Terce Laboratories's EBIT is ₹32.2M making its interest coverage ratio 14.5. It has cash and short-term investments of ₹948.0K.
Belangrijke informatie
44.5%
Verhouding schuld/eigen vermogen
₹39.43m
Schuld
| Rente dekkingsratio | 14.5x |
| Contant | ₹948.00k |
| Aandelen | ₹88.61m |
| Totaal verplichtingen | ₹159.78m |
| Totaal activa | ₹248.39m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 524314's short term assets (₹131.3M) exceed its short term liabilities (₹106.4M).
Langlopende schulden: 524314's short term assets (₹131.3M) exceed its long term liabilities (₹53.4M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 524314's net debt to equity ratio (43.4%) is considered high.
Schuld verminderen: 524314's debt to equity ratio has increased from 19.6% to 44.5% over the past 5 years.
Schuldendekking: 524314's debt is well covered by operating cash flow (32.7%).
Rentedekking: 524314's interest payments on its debt are well covered by EBIT (14.5x coverage).